Gordon Schoenfeld, MD
Radiation Oncology · Athens, GANPI 1437224011
Payments from drug & device makers
What this record shows
Brainlab, Inc. accounts for 67.0% of it on its own, with 34 other manufacturers making up the rest. Reporting peaked in 2019 at $3,431 and has fallen 84.0% since, to $550 in 2025. Among radiation oncology clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 102 payments — averaging $49.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Brainlab, Inc.$3K
- AstraZeneca$163
- Merck$155
- Sirtex Medical Inc$128
- Gilead$90
- Boston Scientific$82
- plus $1K from 29 others
What the payments were for
- Travel & lodging$2,44449%
- Food & beverage$2,57351%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Brainlab, Inc. | 23 | $3,361 |
| AstraZeneca(2 entities) | 8 | $163 |
| Merck | 6 | $155 |
| Sirtex Medical Inc | 1 | $128 |
| Gilead | 4 | $90 |
| Boston Scientific | 4 | $82 |
| Pfizer | 4 | $79 |
| Bayer | 4 | $77 |
| Johnson & Johnson | 3 | $61 |
| Daiichi Sankyo Inc. | 4 | $59 |
| ADC Therapeutics America, Inc. | 4 | $57 |
| Sobi, Inc | 2 | $53 |
| EMD Serono, Inc. | 3 | $48 |
| Exelixis Inc. | 3 | $45 |
| Sumitomo Pharma America, Inc. | 2 | $39 |
| Genentech USA, Inc. | 2 | $37 |
| Organogenesis Inc. | 1 | $37 |
| Stemline Therapeutics Inc. | 2 | $37 |
| Novartis | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Teleflex LLC | 1 | $35 |
| AbbVie | 2 | $35 |
| Genmab U.S., Inc. | 1 | $32 |
| Myriad Genetic Laboratories, Inc. | 2 | $32 |
| GSK | 2 | $29 |
| Iovance Biotherapeutics, Inc. | 1 | $22 |
| AVEO Pharmaceuticals, Inc. | 1 | $20 |
| Merit Medical Systems Inc | 1 | $19 |
| Sanofi | 1 | $18 |
| Telix Pharmaceuticals | 1 | $17 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Eisai Inc. | 1 | $17 |
| Incyte Corporation | 1 | $16 |
| Varian Medical Systems, Inc. | 1 | $15 |
| Agios Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,017 in reported general payments places this provider in the 90th percentile of 165 radiation oncology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other radiation oncology in Athens
- Cole SteberAthens$2K
- Kristin HigginsAtlanta$230K
- Walter CurranAtlanta$83K
- Ian CrockerAtlanta$51K
- Sagar PatelAtlanta$32K
- Hui-Kuo ShuAtlanta$25K
- Wilfred WilliamsAtlanta$15K
- Nancy WiggersAtlanta$11K
- Adam NowlanAtlanta$11K
- Ashesh JaniAtlanta$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.